APA (7th ed.) Citation

M, T., D, B., P, S., A, D. G., M, R., C, S., . . . A, S. (2024). Is Systemic Chemotherapy Useful in Patients Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for Colorectal Peritoneal Metastases? A Propensity-Score Analysis. Annals of surgical oncology, 31(1), 594. https://doi.org/10.1245/s10434-023-14417-z

Chicago Style (17th ed.) Citation

M, Tonello, et al. "Is Systemic Chemotherapy Useful in Patients Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for Colorectal Peritoneal Metastases? A Propensity-Score Analysis." Annals of Surgical Oncology 31, no. 1 (2024): 594. https://doi.org/10.1245/s10434-023-14417-z.

MLA (9th ed.) Citation

M, Tonello, et al. "Is Systemic Chemotherapy Useful in Patients Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for Colorectal Peritoneal Metastases? A Propensity-Score Analysis." Annals of Surgical Oncology, vol. 31, no. 1, 2024, p. 594, https://doi.org/10.1245/s10434-023-14417-z.